PhEur Reference Standards

Article

Most European Pharmacopoeia monographs refer to the use of reference standards (samples of thoroughly characterised substances, intended for use in the tests and assays described in the European Pharmacopoeia). The availability of these standards is essential for the application of the European Pharmacopoeia

PhEur Reference Standards

Most European Pharmacopoeia monographs refer to the use of reference standards (samples of thoroughly characterised substances, intended for use in the tests and assays described in the European Pharmacopoeia). The availability of these standards is essential for the application of the European Pharmacopoeia. The collection of reference standards used for the implementation of the European Pharmacopoeia now consists of more than 2500 substances or mixtures derived from chemical, biological or herbal origin. Their use extends far beyond the European continent. The online database contains over 2500 reference standards and is updated daily. Search by catalogue code, name, monograph or CAS number to find the standard you need. The EDQM also provides Batch Validity Statements, Safety Data Sheets and leaflets to download.

Download the Catalogue today at:
http://crs.edqm.eu/db/4DCGI/web_catalog_CRS

Search the PhEur Reference Standards Database:
http://crs.edqm.eu/

EDQM, Council of Europe
Website: www.edqm.eu & www.edqm.eu/store
E-mail: orders@edqm.eu

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content